Covance Inc. (CVD): Today's Featured Health Care Loser
Covance Inc (CVD) pushed the Health Care sector lower today making it today's featured Health Care loser. The sector as a whole closed the day down 2.7%. By the end of trading, Covance Inc fell $1.98 (-3.9%) to $48.75 on average volume. Throughout the day, 756,456 shares of Covance Inc exchanged hands as compared to its average daily volume of 764,700 shares. The stock ranged in price between $48.28-$49.84 after having opened the day at $48.40 as compared to the previous trading day's close of $50.73. Other company's within the Health Care sector that declined today were: Exelixis Inc (EXEL), down 40.2%, Amedisys Inc (AMED), down 23.4%, BG Medicine Inc (BGMD), down 16.8%, and Zalicus Inc (ZLCS), down 15.7%. Covance Inc., a drug development services company, provides various early-stage and late-stage product development services primarily to the pharmaceutical, biotechnology, and medical device industries worldwide. Covance Inc has a market cap of $3.2 billion and is part of the health services industry. The company has a P/E ratio of 47.2, below the average health services industry P/E ratio of 47.7 and above the S&P 500 P/E ratio of 17.7. Shares are down 1.3% year to date as of the close of trading on Monday. TheStreet Ratings rates Covance as a hold. The company's strengths can be seen in multiple areas, such as its increase in net income, revenue growth and largely solid financial position with reasonable debt levels by most measures. However, as a counter to these strengths, we also find weaknesses including disappointing return on equity and poor profit margins.
- You can view the full Covance Ratings Report.
- Use our health care section to find sector-relevant news.
- Or find some new ideas from our top rated stocks lists.
- Find other investment ideas from our top rated ETFs lists.
Latest Headlines about CVD
-
5 Health Care Stocks Ready to Break Out
11:01AM 04/09/13
-
5 Stocks Hedge Funds Love -- and So Should You
11:25AM 02/06/13
-
TheStreet Ratings Top 10 Rating Changes
03:02PM 12/10/12
-
Covance Management Discusses Q2 2012 Results - Earnings Call Transcript
09:30PM 07/26/12
-
Upgrades Roundup: Lincoln National, Forest Oil
07:02AM 05/07/12
-
Covance's CEO Discusses Q1 2012 Results - Earnings Call Transcript
05:40PM 05/03/12
-
Covance's CEO Discusses Q4 2011 Results - Earnings Call Transcript
03:30PM 01/26/12
Latest from TheStreet Wire
-
Infosys Ltd (INFY): Today's Featured Technology Laggard
05:01PM 05/24/13
-
Williams Companies Inc (WMB): Today's Featured Basic Materials Laggard
05:01PM 05/24/13
-
Trimble Navigation Limited (TRMB): Today's Featured Electronics Laggard
05:01PM 05/24/13
-
Deere & Co (DE): Today's Featured Industrial Laggard
05:01PM 05/24/13
-
Eli Lilly And Company (LLY): Today's Featured Drugs Laggard
05:01PM 05/24/13
-
Sap AG (SAP): Today's Featured Computer Software & Services Laggard
05:01PM 05/24/13
-
Duke Energy Corporation (DUK): Today's Featured Utilities Laggard
05:01PM 05/24/13
Select the service that is right for you!
COMPARE ALL SERVICESAction Alerts PLUS
TRY IT FREEJim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
Product Features:
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Dividend Stock Advisor
TRY IT FREENew! $49.95/yr
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Product Features:
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Stocks Under $10
TRY IT FREEDavid Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
Product Features:
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
- Weekly roundups
Real Money
TRY IT FREE24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.
Product Features:
- Jim Cramer + 20 Wall Street pros
- Intraday commentary & news
- Real-time trading forum
- Actionable trade ideas
Real Money Pro
TRY IT FREEAll of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
Product Features:
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Options Profits
TRY IT FREEOur options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
Product Features:
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV
